Preparation, characterization, and antitumor activity of new cisplatin analogues with 1-methyl-4-(methylamino)piperidine: crystal structure of [PtII(1-methyl-4-(methylamino) piperidine)(oxalate)].
Preparation, characterization, and antitumor activity of new cisplatin analogues with 1-methyl-4-(methylamino)piperidine: crystal structure of [PtII(1-methyl-4-(methylamino) piperidine)(oxalate)].
复制标题
DOI:
10.1016/s0162-0134(02)00614-1
复制
发表时间:
2003-02
影响因子:
3.9
通讯作者:
U. Mukhopadhyay;John H Thurston;K. Whitmire;Z. Siddik;A. Khokhar
中科院分区:
文献类型:
--
作者:
U. Mukhopadhyay;John H Thurston;K. Whitmire;Z. Siddik;A. Khokhar
A series of new platinum(II) complexes of the type [PtII(mmap)X] (where mmap, 1-methyl-4-(methylamino)piperidine and X, 1,1-cyclobutanedicarboxylato (CBDCA), oxalato, malonato, methylmalonato, dimethylmalonato, ethylmalonato, diethylmalonato or 2,3-naphthalene dicarboxylato (NDCA)) have been synthesized and characterized by elemental analysis, infrared (IR), and13C and195Pt nuclear magnetic resonance (NMR) spectroscopy. The crystal structure of the analogue [PtII(mmap)(oxalate)] was determined using the single crystal X-ray diffraction method. Based upon a total of 4964 collected reflections, we determined that the compound crystallizes in the monoclinic space group P21/c (with a=11.890(2) Å, b=9.6695(19) Å, c=9.875(2) Å, β=102.03(3)°, Z=4, and R=0.0428). In this complex, platinum has a slightly distorted square planar geometry with the two adjacent corners being occupied by two nitrogen atoms of the mmap ligand, whereas the remaining cis positions are occupied by two oxygen atoms of the oxalate molecule. The mmap ligand is in a boat conformation and forms six-membered chelating rings as well as the oxalate molecule forms five-membered chelating rings with platinum. The complexes were evaluated for their cytotoxic potential against the sensitive A2780 tumor model and cisplatin-resistant clone derived in vitro from potential cells.